Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

NCT00385606 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG: gemcitabine
DRUG: prolonged continuous infusion gemcitabine
DRUG: cisplatin
DRUG: rofecoxib

Sponsor

National Cancer Institute, Naples